Send feedback

VHL p.Pro86Arg

c.257C>G · rs730882034 · VCV223170

Pathogenic/Likely pathogenic Multiple submitters
Classification
Pathogenic/Likely pathogenic
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 7 submitters
AlphaMissense
likely pathogenic
0.9948 · ACMG-weighted
gnomAD v4.1
Absent
absent from gnomAD v4.1
Missense predictors
3/3 damaging
AlphaMissense, REVEL, SaProt
Conditions
3
von Hippel-Lindau disease

Computational evidence

Protein change
AlphaMissense0.9948likely pathogenic ✓ concordant with ClinVar · top 4% in VHL
REVEL0.88moderately pathogenic-leaning
SaProtLLR -16.25damaging
⇒ AlphaMissense, REVEL and SaProt all call this damaging.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 7.1GERP 1.7, phastCons 1
Regional constrainto/e 1.12unconstrained · MANE · 8,114 bp · p 0.039 · regional, not allelic
Overall
CADD23.4PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes

Absent from gnomAD v4.1. Not observed in any sequenced alleles — a rarity signal (ACMG PM2-supporting), not evidence of pathogenicity on its own.

Cancer therapy — CIViC

DiseaseTherapiesLevelSignificance
Von Hippel-Lindau DiseaseCPredisposition
Von Hippel-Lindau DiseaseCPredisposition
Von Hippel-Lindau DiseaseCUncertain Significance
Von Hippel-Lindau DiseaseCUncertain Significance
Von Hippel-Lindau DiseaseCUncertain Significance
Von Hippel-Lindau DiseaseCUncertain Significance
Von Hippel-Lindau DiseaseC
Von Hippel-Lindau DiseaseC

Variant & gene context

Gene
VHL
Protein
p.Pro86Arg
Coding
c.257C>G
MANE Select
NM_000551
dbSNP
rs730882034
Type
single nucleotide variant
Location
chr3:10142104 (GRCh38)
Gene constraint
LOEUF 0.987 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 85.45 · 143 PDB
Residue 86
a β-strand; a UniProt-annotated variant site (in vhld; type i); a UniProt-annotated variant site (in vhld)
Full VHL gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

von Hippel-Lindau disease — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: Chuvash polycythemiahereditary neoplastic syndrome

For Von Hippel-Lindau disease (Orphanet):

Inheritance
Autosomal dominant
Onset
Adolescent, Adult, Childhood
Prevalence
1-9 / 100 000 (United Kingdom)

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/vhl-p-pro86arg (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown